F2RL3 methylation as a biomarker of current and lifetime smoking exposures

Environmental Health Perspectives

Volumn 122, Issue 2, 2014, Pages 131-137

  Zhang, Yan ^a   Yang, Rongxi ^a,b   Burwinkel, Barbara ^a,b   Breitling, Lutz P ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DNA METHYLATION; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORTALITY; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING CESSATION; TEST RETEST RELIABILITY;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DNA METHYLATION; GERMANY; HUMANS; LINEAR MODELS; MIDDLE AGED; RECEPTORS, THROMBIN; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STATISTICS, NONPARAMETRIC;

EID: 84893387036     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1306937     Document Type: Article

References (48)

1. Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, et al. 2012. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One 7:e46705; doi:10.1371/journal.pone.0046705.
2. Bhutani N, Burns DM, Blau HM. 2011. DNA demethylation dynamics. Cell 146:866-872.
3. Black PC, Mize GJ, Karlin P, Greenberg DL, Hawley SJ, True LD, et al. 2007. Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1,-2, and-4) in prostate cancer. Prostate 67:743-756.
4. Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. 2012. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J 33(22):2841-2848.
5. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. 2011. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 88:450-457.
6. Centers for Disease Control and Prevention. 2010. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. A Report of the Surgeon General. Atlanta GA:Centers for Disease Control and Prevention. Available: http://www.ncbi.nlm.nih.gov/books/NBK53017 [accessed 12 December 2013].
7. Chen HT, Tsou HK, Tsai CH, Kuo CC, Chiang YK, Chang CH, et al. 2010. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway. J Cell Physiol 223:737-745.
8. Desquilbet L, Mariotti F. 2010. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29:1037-1057.
9. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. 1991. How soon after quitting smoking does risk of heart attack decline? J Clin Epidemiol 44:1247-1253.
10. Doll R, Peto R, Boreham J, Sutherland I. 2005. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92:426-429.
11. Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, et al. 2003. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 21:921-926.
12. Falanga A. 2005. Thrombophilia in cancer. Semin Thromb Hemost 31:104-110.
13. Ferrari S, Cribari-Neto F. 2004. Beta regression for modelling rates and proportions. J Appl Stat 31:799-815.
14. Gellert C, Schottker B, Brenner H. 2012. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med 172:837-844.
15. Godschalk RW, Van Schooten FJ, Bartsch H. 2003. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol 36:1-11.
16. Gomides LF, Duarte ID, Ferreira RG, Perez AC, Francischi JN, Klein A. 2012. Proteinase-activated receptor-4 plays a major role in the recruitment of neutrophils induced by trypsin or carrageenan during pleurisy in mice. Pharmacology 89:275-282.
17. Gordon T, Kannel WB, McGee D, Dawber TR. 1974. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham Study. Lancet 2:1345-1348.
18. Gouin-Thibault I, Samama MM. 1999. Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost 25:167-172.
19. Gratio V, Walker F, Lehy T, Laburthe M, Darmoul D. 2009. Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase. Int J Cancer 124:1517-1525.
20. Hrubec Z, McLaughlin JK. 2007. Changes in cigarette-related disease risks and their implications for prevention and control. In: Smoking and Tobacco Control Monograph No. 8. NIH Publication no. 97-4213. Washington, DC:National Cancer Institute. Available: http://cancercontrol.cancer.gov/brp/tcrb/monographs/8/index.html [accessed 13 November 2013].
21. Hughes JR, Keely J, Naud S. 2004. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99:29-38.
22. Jacobs DR Jr, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, et al. 1999. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 159:733-740.
23. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A, et al. 2003. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102:3224-3231.
24. Kaufmann R, Rahn S, Pollrich K, Hertel J, Dittmar Y, Hommann M, et al. 2007. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4. J Cell Physiol 211:699-707.
25. Kondo T, Osugi S, Shimokata K, Honjo H, Morita Y, Maeda K, et al. 2011. Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers. Circ J 75:2885-2892.
26. Kramer A, Jansen AC, van Aalst-Cohen ES, Tanck MW, Kastelein JJ, Zwinderman AH. 2006. Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6-9 years excess risk in individuals with familial hypercholesterolemia. BMC Public Health 6:262; doi:10.1186/1471-2458-6-262.
27. Leger AJ, Covic L, Kuliopulos A. 2006. Protease-activated receptors in cardiovascular diseases. Circulation 114:1070-1077.
28. Leone A. 2007. Smoking, haemostatic factors, and cardiovascular risk. Curr Pharm Des 13:1661-1667.
29. Lightwood JM, Glantz SA. 1997. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 96:1089-1096.
30. Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, et al. 2010. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 29:3650-3664.
31. Lodovici M, Bigagli E. 2009. Biomarkers of induced active and passive smoking damage. Int J Environ Res Public Health 6:874-888.
32. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. 2001. Proteinase-activated receptors. Pharmacol Rev 53:245-282.
33. Mathers CD, Loncar D. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442; doi:10.1371/journal.pmed.0030442.
34. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
35. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. 2000. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321:323-329.
36. Rahman MM, Laher I. 2007. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 5:276-292.
37. Raum E, Rothenbacher D, Low M, Stegmaier C, Ziegler H, Brenner H. 2007. Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil 14:809-814.
38. Satta R, Maloku E, Zhubi A, Pibiri F, Hajos M, Costa E, et al. 2008. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc Natl Acad Sci USA 105:16356-16361.
39. Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA, et al. 2013. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 22:843-851.
40. Smith MR, Kinmonth AL, Luben RN, Bingham S, Day NE, Wareham NJ, et al. 2003. Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis 169:331-337.
41. Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification. 2002. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4:149-159.
42. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, et al. 2005. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26:1-43.
43. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. 2006. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368:647-658.
44. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. 2010. The global burden of cancer: priorities for prevention. Carcinogenesis 31:100-110.
45. Vergnolle N, Derian CK, D'Andrea MR, Steinhoff M, Andrade-Gordon P. 2002. Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. J Immunol 169:1467-1473.
46. Wan ES, Qiu W, Baccarelli A, Carey VJ, Bacherman H, Rennard SI, et al. 2012. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet 21:3073-3082.
47. Wu HC, Delgado-Cruzata L, Flom JD, Kappil M, Ferris JS, Liao Y, et al. 2011. Global methylation profiles in DNA from different blood cell types. Epigenetics 6:76-85.
48. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, et al. 1998. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95:6642-6646.